Cargando…
Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a lethal malignancy with high mortality and lack of effective therapeutic targets. Here, we found that expression of cyclin-dependent kinase 7 (CDK7) was significantly associated with higher tumor grade and worse prognosis in 96 ICC specimens. Depletion of CD...
Autores principales: | Chen, Hua-Dong, Huang, Chen-Song, Xu, Qiong-Cong, Li, Fuxi, Huang, Xi-Tai, Wang, Jie-Qin, Li, Shi-Jin, Zhao, Wei, Yin, Xiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053328/ https://www.ncbi.nlm.nih.gov/pubmed/32174795 http://dx.doi.org/10.7150/ijbs.39779 |
Ejemplares similares
-
Targeting Super‐Enhancers via Nanoparticle‐Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma
por: Huang, Chen‐Song, et al.
Publicado: (2020) -
METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner
por: Xu, Qiong-Cong, et al.
Publicado: (2022) -
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
por: Li, Jian-Hui, et al.
Publicado: (2019) -
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21
por: Kawamura, Etsushi, et al.
Publicado: (2022) -
YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation
por: Huang, Chen‐Song, et al.
Publicado: (2022)